Suchergebnisse - "D'Arena, Giovanni"

PubPharm (10)

1

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2019

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

2

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2018

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

3

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2018

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

4

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2018

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

5

Unusual Hypergranular Myelomatous Plasma Cells

enthalten in: Indian journal of hematology & blood transfusion | 2017

von D’Arena, G. | Musto, P.

6

Unusual Hypergranular Myelomatous Plasma Cells

enthalten in: Indian journal of hematology and blood transfusion | 2017

von D’Arena, G. | Musto, P.

7

Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell’Adulto Multiple Myeloma Working Party study

enthalten in: Stem cell research & therapy | 2015

von Musto, P. | Simeon, V. | Grossi, A. | +19

8

Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell’Adulto Multiple Myeloma Working Party study

enthalten in: Stem cell research & therapy | 2015

von Musto, P. | Simeon, V. | Grossi, A. | +19

9

Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia

enthalten in: British journal of haematology | 2012

von Gozzetti, A. | Musto, P. | Defina, M. | +6

ErratumIn: Br J Haematol. 2012 Aug;158(3):430 Steduto, Teodora [corrected to Statuto, Teodora]

10

Efficacy and safety of bortezomib in patients with plasma cell leukemia

enthalten in: Cancer | 2007

von Musto, P. | Rossini, F. | Gay, F. | +10

1
[1]